(Post-pandemic Era) - Global The Veterinary Biologics Market Segment Research Report 2021

(Post-pandemic Era) - Global The Veterinary Biologics Market Segment Research Report 2021

Table of Contents

Global The Veterinary Biologics Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global The Veterinary Biologics Market by Value
2.2.1 Global The Veterinary Biologics Revenue by Type
2.2.2 Global The Veterinary Biologics Market by Value (%)
2.3 Global The Veterinary Biologics Market by Production
2.3.1 Global The Veterinary Biologics Production by Type
2.3.2 Global The Veterinary Biologics Market by Production (%)

3. The Major Driver of The Veterinary Biologics Industry
3.1 Historical & Forecast Global The Veterinary Biologics Demand
3.2 Largest Application for The Veterinary Biologics (2017-2027)
3.3 The Major Downstream Company in China Market 2021

4. Global and Regional The Veterinary Biologics Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of The Veterinary Biologics Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US The Veterinary Biologics Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe The Veterinary Biologics Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China The Veterinary Biologics Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan The Veterinary Biologics Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India The Veterinary Biologics Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea The Veterinary Biologics Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia The Veterinary Biologics Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global The Veterinary Biologics Average Price Trend
12.1 Market Price for Each Type of The Veterinary Biologics in US (2017-2021)
12.2 Market Price for Each Type of The Veterinary Biologics in Europe (2017-2021)
12.3 Market Price for Each Type of The Veterinary Biologics in China (2017-2021)
12.4 Market Price for Each Type of The Veterinary Biologics in Japan (2017-2021)
12.5 Market Price for Each Type of The Veterinary Biologics in India (2017-2021)
12.6 Market Price for Each Type of The Veterinary Biologics in Korea (2017-2021)
12.7 Market Price for Each Type of The Veterinary Biologics in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
13.1 The Veterinary Biologics Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of The Veterinary Biologics

14. The Veterinary Biologics Competitive Landscape
14.1 Merck
14.1.1 Merck Company Profiles
14.1.2 Merck Product Introduction
14.1.3 Merck The Veterinary Biologics Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Yebio
14.2.1 Yebio Company Profiles
14.2.2 Yebio Product Introduction
14.2.3 Yebio The Veterinary Biologics Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Ceva
14.3.1 Ceva Company Profiles
14.3.2 Ceva Product Introduction
14.3.3 Ceva The Veterinary Biologics Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Zoetis
14.4.1 Zoetis Company Profiles
14.4.2 Zoetis Product Introduction
14.4.3 Zoetis The Veterinary Biologics Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Ringpu Biology
14.5.1 Ringpu Biology Company Profiles
14.5.2 Ringpu Biology Product Introduction
14.5.3 Ringpu Biology The Veterinary Biologics Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Boehringer Ingelheim
14.6.1 Boehringer Ingelheim Company Profiles
14.6.2 Boehringer Ingelheim Product Introduction
14.6.3 Boehringer Ingelheim The Veterinary Biologics Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 WINSUN
14.7.1 WINSUN Company Profiles
14.7.2 WINSUN Product Introduction
14.7.3 WINSUN The Veterinary Biologics Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 HVRI
14.8.1 HVRI Company Profiles
14.8.2 HVRI Product Introduction
14.8.3 HVRI The Veterinary Biologics Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 CAHIC
14.9.1 CAHIC Company Profiles
14.9.2 CAHIC Product Introduction
14.9.3 CAHIC The Veterinary Biologics Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
14.10 DHN
14.10.1 DHN Company Profiles
14.10.2 DHN Product Introduction
14.10.3 DHN The Veterinary Biologics Sales, Revenue (2017-2021)
14.10.4 Strategic initiatives
14.11 CAVAC
14.12 Vaksindo
14.13 Elanco/Eli Lilly
14.14 Avimex Animal
14.15 Kyoto Biken
14.16 ChengDu Tecbond
14.17 Virbac
14.18 Bio-Labs
14.19 FATRO
14.20 Jinyu Bio-Technology
15. Conclusion

List of Tables and Figures

Figure 1. Total Demand by Application of The Veterinary Biologics Industry (Volume)
Figure 2. The Veterinary Biologics Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by The Veterinary Biologics Revenue in 2021
Figure 5. US The Veterinary Biologics Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe The Veterinary Biologics Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China The Veterinary Biologics Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan The Veterinary Biologics Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India The Veterinary Biologics Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea The Veterinary Biologics Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia The Veterinary Biologics Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. The Veterinary Biologics Revenue, by Type (Million USD) (2017-2027)
Table 4. The Veterinary Biologics Production, by Type (K Unit) (2017-2027)
Table 5. The Veterinary Biologics Demand (K Unit) by Application (2017-2027)
Table 6. The Veterinary Biologics Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top The Veterinary Biologics Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia The Veterinary Biologics Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of The Veterinary Biologics in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Merck Profiles
Table 61. Merck The Veterinary Biologics Product Introduction
Table 62. Merck The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Merck Strategic initiatives
Table 64. Yebio Profiles
Table 65. Yebio The Veterinary Biologics Product Introduction
Table 66. Yebio The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Yebio Strategic initiatives
Table 68. Ceva Profiles
Table 69. Ceva The Veterinary Biologics Product Introduction
Table 70. Ceva The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Ceva Strategic initiatives
Table 72. Zoetis Profiles
Table 73. Zoetis The Veterinary Biologics Product Introduction
Table 74. Zoetis The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Zoetis Strategic initiatives
Table 76. Ringpu Biology Profiles
Table 77. Ringpu Biology The Veterinary Biologics Product Introduction
Table 78. Ringpu Biology The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. Ringpu Biology Strategic initiatives
Table 80. Boehringer Ingelheim Profiles
Table 81. Boehringer Ingelheim The Veterinary Biologics Product Introduction
Table 82. Boehringer Ingelheim The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Boehringer Ingelheim Strategic initiatives
Table 84. WINSUN Profiles
Table 85. WINSUN The Veterinary Biologics Product Introduction
Table 86. WINSUN The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. WINSUN Strategic initiatives
Table 88. HVRI Profiles
Table 89. HVRI The Veterinary Biologics Product Introduction
Table 90. HVRI The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. HVRI Strategic initiatives
Table 92. CAHIC Profiles
Table 93. CAHIC The Veterinary Biologics Product Introduction
Table 94. CAHIC The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 95. CAHIC Strategic initiatives
Table 97. DHN Profiles
Table 98. DHN The Veterinary Biologics Product Introduction
Table 99. DHN The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 100. DHN Strategic initiatives
Table 101. CAVAC Profiles
Table 102. CAVAC The Veterinary Biologics Product Introduction
Table 103. CAVAC The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 104. CAVAC Strategic initiatives
Table 105. Vaksindo Profiles
Table 106. Vaksindo The Veterinary Biologics Product Introduction
Table 107. Vaksindo The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 108. Vaksindo Strategic initiatives
Table 109. Elanco/Eli Lilly Profiles
Table 110. Elanco/Eli Lilly The Veterinary Biologics Product Introduction
Table 111. Elanco/Eli Lilly The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 112. Elanco/Eli Lilly Strategic initiatives
Table 113. Avimex Animal Profiles
Table 114. Avimex Animal The Veterinary Biologics Product Introduction
Table 115. Avimex Animal The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 116. Avimex Animal Strategic initiatives
Table 117. Kyoto Biken Profiles
Table 118. Kyoto Biken The Veterinary Biologics Product Introduction
Table 119. Kyoto Biken The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 120. Kyoto Biken Strategic initiatives
Table 121. ChengDu Tecbond Profiles
Table 122. ChengDu Tecbond The Veterinary Biologics Product Introduction
Table 123. ChengDu Tecbond The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 124. ChengDu Tecbond Strategic initiatives
Table 125. Virbac Profiles
Table 126. Virbac The Veterinary Biologics Product Introduction
Table 127. Virbac The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 128. Virbac Strategic initiatives
Table 129. Bio-Labs Profiles
Table 130. Bio-Labs The Veterinary Biologics Product Introduction
Table 131. Bio-Labs The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 132. Bio-Labs Strategic initiatives
Table 133. FATRO Profiles
Table 134. FATRO The Veterinary Biologics Product Introduction
Table 135. FATRO The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)
Table 136. FATRO Strategic initiatives
Table 137. Jinyu Bio-Technology Profiles
Table 138. Jinyu Bio-Technology The Veterinary Biologics Product Introduction
Table 139. Jinyu Bio-Technology The Veterinary Biologics Sales (Unit), Revenue (Million USD) (2017-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Classical Swine Fever Vaccines Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......

Global Tylosin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......

Global Animal Parasiticides Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......

Global Newcastle Disease Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......

Global Classical Swine Fever Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126

According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......

Global Veterinary Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151

According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......

Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134

According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......

Global Veterinary Products for Companion Animals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109

According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......

Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115

According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs